Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview

Michael "Mike" Pearson, chairman and chief executive officer of Valeant Pharmaceuticals International Inc., smiles during a Bloomberg Television interview in New York, U.S., on Wednesday, April 23, 2014. With his $45.7 billion bid for Allergan Inc., Pearson is pulling the credit rating of Canada's most indebted junk bond issuer closer to investment grade while attempting the biggest takeover in the country's history. Photographer: Scott Eells/Bloomberg via Getty Images
Michael "Mike" Pearson, chairman and chief executive officer of Valeant Pharmaceuticals International Inc., smiles during a Bloomberg Television interview in New York, U.S., on Wednesday, April 23, 2014. With his $45.7 billion bid for Allergan Inc., Pearson is pulling the credit rating of Canada's most indebted junk bond issuer closer to investment grade while attempting the biggest takeover in the country's history. Photographer: Scott Eells/Bloomberg via Getty Images
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
PURCHASE A LICENCE
How can I use this image?
₹23,000.00
INR

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
486251779
Collection:
Bloomberg
Date created:
23 April, 2014
Upload date:
Licence type:
Rights-managed
Release info:
Not released. More information
Source:
Bloomberg
Object name:
VALEANT PERSHING